Free Trial
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel
NASDAQ:YI

111 Q2 2025 Earnings Results & Report

111 logo
$3.09 -0.02 (-0.64%)
Closing price 03:59 PM Eastern
Extended Trading
$3.08 -0.01 (-0.29%)
As of 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

111 reported Q2 2025 earnings on September 17, 2025. The company reported EPS of -$0.40, while revenue was $447.51 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q2 2025
Report Date
Time
Before Market Opens
Conference Call Date
Conference Call
6:00 PM ET

111 EPS Results

Actual EPS
-$0.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

111 Revenue Results

Actual Revenue
$447.51 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

111's Q3 2026 earnings is estimated for Thursday, November 26, 2026, based on past reporting schedules

Conference Call Resources

Powered by Quartr

Earnings Documents

111's Q2 2025 Earnings ReleaseEarnings Release
(6-K)

111 Q2 2025 Earnings FAQ

111 (NASDAQ:YI) reported earnings of -$0.40 per share for Q2 2025. The report was announced on Wednesday, September 17, 2025.

111 reported revenue of $447.51 million for Q2 2025.

111's next earnings date is estimated for Thursday, November 26, 2026. MarketBeat tracks confirmed and estimated earnings dates for 111 on the company's earnings history page.

111 Earnings Headlines

Critical Contrast: Tempus AI (NASDAQ:TEM) and 111 (NASDAQ:YI)
October 11, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31107789
111, Inc. Announces Establishment of Special Committee
September 28, 2026  |  marketscreener.comM
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
October 15 at 1:00 AM  |  Stansberry Research (Ad)
111 Forms Special Committee To Review Takeover Proposal And Strategic Options
September 28, 2026  |  rttnews.comhttps://www.rttnews.com/3694256/111-forms-special-committee-to-review-takeover-proposal-and-strategic-options.aspx
111, Inc. Announces Establishment of the Special Committee
September 28, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/111-inc-announces-establishment-of-the-special-committee-302891226.html
111, Inc Q2 Loss Widens From Lower Revenue; Shares Up
September 17, 2026  |  rttnews.comhttps://www.rttnews.com/3692015/111-inc-q2-loss-widens-from-lower-revenue-shares-up.aspx
See More 111 Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 111? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 111 and other key companies, straight to your email.

About 111

111 (NASDAQ:YI), Inc. (NASDAQ: YI) is a China-based technology-enabled healthcare platform that connects consumers, healthcare providers, pharmacies and pharmaceutical companies. The company focuses on improving access to healthcare products and services through digital tools and an integrated online and offline operating model.

Its business activities include online retailing and distribution of prescription and over-the-counter medicines, health products, medical devices and other healthcare-related goods. Through its digital platforms, 111 also provides medication information, health-management resources and other services intended to support consumers and healthcare professionals.

111 serves customers and business partners primarily in China. The company was founded in 2010 and has developed operations spanning consumer healthcare, pharmaceutical distribution and technology services. Its platforms are designed to connect pharmaceutical manufacturers with hospitals, pharmacies, clinics and individual consumers across the Chinese healthcare market.

111, Inc. was co-founded by Junling Liu, who has served as the company’s chief executive officer. The company completed its initial public offering on the Nasdaq Stock Market in 2018.

View 111 Profile
Earnings Tools